Ovalis Raises Series B

Ovalis Inc., a < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Mountain View, Calif.-based developer of catheter-based products for repairing cardiac defects, has raised around $6.6 million in Series B funding, according to a regulatory filing. Return backers include Abbott Labs, De Novo Ventures and Latterell Venture Partners.